You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

ID: GL-C50-30 fév 2017
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
CCO Systemic Treatment, Canadian Association of Provincial Cancer Agencies

Guideline Objective

These recommendations were developed to address the safe handling of oral anti cancer drugs (OACDs) in community pharmacies across the medication lifecycle, from manufacturer packaging to waste management and incident reporting.

Intended Guideline Users

Pharmacists